Maxigen Biotech (TPE:1783) E10: NT$1.28 (As of Dec. 2025)


TPE:1783 Maxigen Biotech Inc TPE:1783
87 GF Score
Price NT$38.10
GF Value NT$60.99
Valuation Significantly Undervalued
View Full Analysis

What is Maxigen Biotech E10?

Maxigen Biotech TPE:1783 -1.55% 87 E10 is NT$1.28 as of Dec. 2025. GuruFocus rates TPE:1783 with a GF Score™ of 87/100 and a GF Value™ of NT$60.99 (Significantly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Maxigen Biotech's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$0.930. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$1.28 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Maxigen Biotech's average E10 Growth Rate was 48.80% per year. During the past 3 years, the average E10 Growth Rate was 47.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Maxigen Biotech was 53.00% per year. The lowest was 47.40% per year. And the median was 50.20% per year.

As of today (2026-06-29), Maxigen Biotech's current stock price is NT$38.10. Maxigen Biotech's E10 for the quarter that ended in Dec. 2025 was NT$1.28. Maxigen Biotech's Shiller PE Ratio of today is 29.77.

During the past 13 years, the highest Shiller PE Ratio of Maxigen Biotech was 339.94. The lowest was 29.65. And the median was 81.86.


Maxigen Biotech  (TPE:1783) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Maxigen Biotech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=38.10/1.28
=29.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Maxigen Biotech was 339.94. The lowest was 29.65. And the median was 81.86.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Maxigen Biotech E10 Related Terms


Maxigen Biotech E10 Historical Data

* Premium members only.

The historical data trend for Maxigen Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maxigen Biotech E10 Chart

Maxigen Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.40 0.60 0.86 1.28

Maxigen Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.95 1.05 1.15 1.28

TPE:1783 vs ISRG, BDX, MDLN: E10 Comparison

For the Medical Instruments & Supplies subindustry, Maxigen Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maxigen Biotech Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Maxigen Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Maxigen Biotech's Shiller PE Ratio falls into.


TPE:1783
87GF Score
Maxigen Biotech Inc TPE:1783
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maxigen Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Maxigen Biotech's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0.93/324.0540*324.0540
=0.930

Current CPI (Dec. 2025) = 324.0540.

Maxigen Biotech Quarterly Data

per share eps CPI Adj_EPS
201603 -0.139 238.132 -0.189
201606 -0.043 241.018 -0.058
201609 -0.017 241.428 -0.023
201612 0.035 241.432 0.047
201703 -0.052 243.801 -0.069
201706 0.104 244.955 0.138
201709 0.095 246.819 0.125
201712 0.043 246.524 0.057
201803 0.104 249.554 0.135
201806 0.268 251.989 0.345
201809 0.208 252.439 0.267
201812 0.087 251.233 0.112
201903 0.087 254.202 0.111
201906 0.303 256.143 0.383
201909 0.225 256.759 0.284
201912 0.095 256.974 0.120
202003 0.130 258.115 0.163
202006 0.260 257.797 0.327
202009 0.156 260.280 0.194
202012 0.251 260.474 0.312
202103 0.268 264.877 0.328
202106 0.268 271.696 0.320
202109 0.364 274.310 0.430
202112 0.138 278.802 0.160
202203 0.229 287.504 0.258
202206 0.371 296.311 0.406
202209 0.470 296.808 0.513
202212 0.480 296.797 0.524
202303 0.520 301.836 0.558
202306 0.700 305.109 0.743
202309 0.460 307.789 0.484
202312 0.190 306.746 0.201
202403 0.320 312.332 0.332
202406 0.660 314.175 0.681
202409 0.560 315.301 0.576
202412 0.580 315.605 0.596
202503 0.520 319.799 0.527
202506 0.660 322.561 0.663
202509 0.840 324.800 0.838
202512 0.930 324.054 0.930

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$1.28 mean?
Maxigen Biotech (TPE:1783) has a E10 of NT$1.28 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Maxigen Biotech and its competitors.
Is Maxigen Biotech's E10 too high?
Maxigen Biotech's current E10 is NT$1.28. Overall, Maxigen Biotech has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maxigen Biotech's E10 compare to ISRG and BDX?
Maxigen Biotech's E10 of NT$1.28 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Maxigen Biotech and its competitors. Maxigen Biotech's current E10 is NT$1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maxigen Biotech stock overvalued right now?
Based on GuruFocus' analysis, Maxigen Biotech (TPE:1783) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$60.99, compared to a current price of NT$38.10 — trading 37.5% below its estimated fair value. The current E10 is NT$1.28. Maxigen Biotech's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Maxigen Biotech (TPE:1783), the current E10 is NT$1.28 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maxigen Biotech (TPE:1783) Overvalued in 2026?

Based on GuruFocus' analysis, Maxigen Biotech stock appears to be undervalued. The current stock price of NT$38.10 is trading 37.5% below its estimated GF Value™ of NT$60.99. GuruFocus considers Maxigen Biotech to be Significantly Undervalued.

Key valuation signals for TPE:1783:

  • E10: NT$1.28
  • GF Value™: NT$60.99 vs. price of NT$38.10 (37.5% below fair value)
  • GF Score™: 87/100

No single metric tells the full story. See the TPE:1783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Maxigen Biotech Business Description

Address No.88, Keji 1st Road, Guishan District, Taoyuan City, TWN, 333
Maxigen Biotech Inc is engaged in collagen purification, research and development, production and sales of implantable medical device, and production, manufacturing, wholesale and retail of cosmetics. The group had two reportable segments: the biomedical products segment and consumer products segment. Biomedical products segment is engaged in the manufacturing and sales of collagen and bone materials. The consumer products segment is involved in the manufacturing and sales of beauty care products. Geographically, it operates in Taiwan, America, Europe, Asia, and other countries, with the majority of the revenue deriving from Taiwan.
87GF Score

Get the complete analysis for TPE:1783

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.10
Price
NT$60.99
GF Value